OSE fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
OSE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company